Details of Disease

General Information of Disease (ID: DISFSDLO)

Disease Name Cerebrovascular ischaemia
Disease Class 8B1Z: Cerebral ischaemia
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISFSDLO: Cerebrovascular ischaemia
ICD Code
ICD-11
ICD-11: 8B1Z
ICD-10
ICD-10: I67.8
ICD-9
ICD-9: 434.91
Expand ICD-11
'8B1Z
Expand ICD-10
'I67.8
Expand ICD-9
434.91
Disease Identifiers
MONDO ID
MONDO_0005299
MESH ID
D002545
UMLS CUI
C0917798
MedGen ID
182975
HPO ID
HP:0002637
SNOMED CT ID
287731003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 10 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Ademetionine DMYQDBO Approved Small molecular drug [1]
Aniracetam DMOIFW0 Approved Small molecular drug [2]
Asasantin DMCZIHT Approved Small molecular drug [3]
BETRIXABAN DM2C4RF Approved Small molecular drug [4]
Citicoline DMI4XBM Approved Small molecular drug [5]
Drotrecogin alfa DM59JCN Approved NA [6]
Ganglioside gm1 DM0KT0Q Approved Small molecular drug [5]
Monosialoganglioside DMU8PGS Approved NA [5]
Nafronyl DMVMQ1L Approved Small molecular drug [5]
Coenzyme Q10 DM8D9H5 Phase 4 Small molecular drug [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
This Disease is Treated as An Indication in 22 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Stempeucel DMS7XFS Preregistration NA [8]
BB3 DMZ8AL8 Phase 3 Small molecular drug [9]
Tat-NR2B9c DMD6AUX Phase 3 Peptide [10]
Tecarfarin DMTCR2O Phase 3 Small molecular drug [11]
Arimoclomol DMS8QF9 Phase 2/3 Small molecular drug [12]
3K3A-APC DMTLR6Y Phase 2 NA [13]
ALD-401 DM2U530 Phase 2 NA [14]
APG-101 DM0FXMZ Phase 2 NA [15]
NSI-566 DMHHXC9 Phase 2 NA [16]
SB-623 DM4NY58 Phase 2 Small molecular drug [17]
SUN-13837 DMZY7FW Phase 2 NA [18]
CEP-9722 DMY8NUF Phase 1/2 NA [19]
HTU-PA DMNHE43 Phase 1/2 NA [20]
Perfluoropropane gas-filled nanobubbles DMCNIR1 Phase 1/2 NA [21]
CIGB-500 DM8XM72 Phase 1 NA [22]
CNTO-0007 DMK2R2M Phase 1 NA [23]
Mesenchymal bone marrow-derived stem cell therapy DMEFTSW Phase 1 NA [24]
NX-CP105 DM9MWHC Phase 1 NA [25]
ReN-001 DMTYVIU Phase 1 NA [26]
SAR-104772 DMQ9ZY0 Phase 1 NA [27]
SAR-126119 DMKHM7O Phase 1 NA [28]
ZD-9379 DM3KYO4 Phase 1 NA [29]
------------------------------------------------------------------------------------
⏷ Show the Full List of 22 Drug(s)
This Disease is Treated as An Indication in 46 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Sabeluzole DMSW051 Discontinued in Phase 3 Small molecular drug [30]
Selfotel DM3FLIX Discontinued in Phase 3 Small molecular drug [31]
E-2001 DM485H3 Discontinued in Phase 1 Small molecular drug [32]
MLN-2201 DMQA5JW Discontinued in Phase 1 Antibody [33]
ONO-2231 DM8KN2M Discontinued in Phase 1 NA [34]
S-1746 DMRXB8F Discontinued in Phase 1 NA [35]
SL-65.1708 DM2ERIO Discontinued in Phase 1 NA [36]
T-2000 DMKHPDI Discontinued in Phase 1 Small molecular drug [37]
TAK-937 DM13YN0 Discontinued in Phase 1 NA [38]
ACEA-1031 DMCWNVB Terminated NA [42]
ACEA-1416 DMRHSG4 Terminated NA [43]
AJ-3941 DMOJTZV Terminated Small molecular drug [44]
AX-201 DMLE1W3 Terminated NA [45]
BBB-022 DMITV4F Terminated NA [46]
BMS-183729 DMHP770 Terminated NA [47]
BW-1003C87 DMEP9B6 Terminated Small molecular drug [48]
CNS-1237 DMP3QAZ Terminated NA [49]
CNS-5788 DMZY0SF Terminated Small molecular drug [50]
Darodipine DM160FM Terminated Small molecular drug [51]
Diaspirin crosslinked hemoglobin DM61BWZ Terminated NA [52]
DIZOCILPINE DMMGYXR Terminated Small molecular drug [53]
E-2050 DMQKEHA Terminated NA [54]
Emopamil DMW210B Terminated Small molecular drug [55]
FR-115427 DMY2IB8 Terminated Small molecular drug [56]
GLI-5021 DMSH41K Terminated NA [57]
GLY-515n DM0IKB4 Terminated NA [58]
GPI-16552 DMTJ25U Terminated NA [59]
GPI-3000 DMBMAPH Terminated Small molecular drug [60]
HF-0699 DMUY80O Terminated NA [61]
L-701324 DMAIJSX Terminated Small molecular drug [62]
M-241247 DMIY51U Terminated NA [63]
M-40401 DMBFCHW Terminated NA [64]
MDL-101002 DMSBHF4 Terminated NA [65]
NNC-09-0026 DMGEHZ9 Terminated Small molecular drug [66]
NOX-151 DMK7L1Z Terminated NA [67]
NPS-1392 DMTWXE3 Terminated NA [68]
NPS-846 DMNL1VM Terminated NA [69]
NS-1608 DMYV9M1 Terminated Small molecular drug [70]
NS-257 DM9F81Z Terminated NA [71]
NS-638 DMPT74G Terminated Small molecular drug [72]
PD-158473 DMS1XK5 Terminated Small molecular drug [73]
PD-159913 DMJ5STO Terminated Small molecular drug [74]
PNQX DMT83V6 Terminated NA [75]
SB-206284A DM5ZPQJ Terminated NA [76]
TP-20 DM5ZNSQ Terminated NA [77]
VA-045 DMYZEF6 Terminated Small molecular drug [78]
------------------------------------------------------------------------------------
⏷ Show the Full List of 46 Drug(s)
This Disease is Treated as An Indication in 3 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
NPS-2390 DMMRY0Z Preclinical Small molecular drug [39]
NTC-100 DMLEMWN Preclinical NA [40]
SCIO-323 DMDCT6D Preclinical NA [41]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 22 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AIK-21 DM4Z31F Investigative NA [79]
ANG-2684 DMDLVH5 Investigative NA [80]
Axogenesis Factor-1 DMT5P8O Investigative NA [81]
CTCE-0501 DMPZR3Y Investigative NA [79]
EP-37 DMHN82B Investigative NA [82]
FG-4497 DMYK9KI Investigative NA [79]
Flavonols DM8AOPT Investigative NA [79]
INV-155 DM4ALNK Investigative NA [79]
LJP-1207 DMJ108U Investigative NA [83]
M5 DM3IX2E Investigative Small molecular drug [84]
Neomedi DMD61HM Investigative NA [79]
NGN-9078 DMFYGOC Investigative NA [79]
NK-102 DMJ8I5Y Investigative NA [79]
NT-KC-005 DM7VDFN Investigative NA [79]
Peptagon DM0S5XW Investigative NA [79]
Placental growth factor DM27T96 Investigative NA [85]
PN-277 DMUGGOL Investigative NA [79]
Recombinant plasmin DM2IOJF Investigative NA [79]
SEA-0400 DME69PI Investigative Small molecular drug [86]
SMND-309 DMXPQ1A Investigative Small molecular drug [79]
SMRX-11 DM4CSBZ Investigative NA [79]
TGF alpha DMOX3AH Investigative NA [87]
------------------------------------------------------------------------------------
⏷ Show the Full List of 22 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4786).
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4133).
3 Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.
4 ClinicalTrials.gov (NCT01583218) Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study). U.S. National Institutes of Health.
5 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6788).
7 ClinicalTrials.gov (NCT01660191) A Study Comparing CoQ10 Levels While Taking 3 Different Statins. U.S. National Institutes of Health.
8 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034821)
9 Clinical pipeline report, company report or official report of Angion Therapeutics.
10 Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature. 2012 Feb 29;483(7388):213-7.
11 ClinicalTrials.gov (NCT02522221) Tecarfarin Anti-Coagulation Trial (TACT).
12 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8271).
13 ClinicalTrials.gov (NCT02222714) Safety Evaluation of 3K3A-APC in Ischemic Stroke. U.S. National Institutes of Health.
14 ClinicalTrials.gov (NCT01273337) Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects. U.S. National Institutes of Health.
15 ClinicalTrials.gov (NCT01071837) APG101 in Glioblastoma. U.S. National Institutes of Health.
16 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025566)
17 ClinicalTrials.gov (NCT02448641) Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke. U.S. National Institutes of Health.
18 ClinicalTrials.gov (NCT01502631) Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI). U.S. National Institutes ofHealth.
19 ClinicalTrials.gov (NCT01311713) Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors. U.S. National Institutes of Health.
20 ClinicalTrials.gov (NCT00418275) Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.. U.S. National Institutes of Health.
21 ClinicalTrials.gov (NCT00504842) Transcranial Ultrasound in Clinical SONothrombolysis. U.S. National Institutes of Health.
22 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800038513)
23 ClinicalTrials.gov (NCT01273467) A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Knownas Stroke). U.S. National Institutes of Health.
24 Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013 Jun;34(6):747-54.
25 ClinicalTrials.gov (NCT00361855) Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle. U.S. National Institutes of Health.
26 ClinicalTrials.gov (NCT01151124) Pilot Investigation of Stem Cells in Stroke. U.S. National Institutes of Health.
27 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028193)
28 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034720)
29 Neuroprotective potential of ionotropic glutamate receptor antagonists. Neurotox Res. 2002 Mar;4(2):119-26.
30 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000207)
31 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4155).
32 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003075)
33 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010178)
34 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022742)
35 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016496)
36 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014724)
37 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014289)
38 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030875)
39 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1384).
40 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016424)
41 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019057)
42 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008256)
43 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007961)
44 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002238)
45 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018792)
46 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009640)
47 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003456)
48 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002740)
49 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001959)
50 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013711)
51 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000417)
52 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005412)
53 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2403).
54 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016308)
55 Calcium entry and 5-HT2 receptor blockade in oliguric ischaemic acute renal failure: effects of levemopamil in conscious rats. Br J Pharmacol. 1996 Mar;117(6):1348-54.
56 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009401)
57 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017382)
58 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027536)
59 Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res. 2003 Jul 18;978(1-2):99-103.
60 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001817)
61 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019947)
62 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4240).
63 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003415)
64 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018067)
65 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010237)
66 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003940)
67 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010854)
68 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013127)
69 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007143)
70 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006351)
71 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002246)
72 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005354)
73 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008060)
74 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008061)
75 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010041)
76 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007384)
77 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010273)
78 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001378)
79 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
80 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2771).
81 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1888).
82 Semuloparin for the prevention of venous thromboembolic events in cancer patients. Drugs Today (Barc). 2012 Jul;48(7):451-7.
83 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2767).
84 Tranexamic acid in trauma: how should we use it. J Trauma Acute Care Surg. 2013 Jun;74(6):1575-86.
85 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5314).
86 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4617).
87 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5059).